Allianz Global Investors Fund - Allianz Climate Transition PT2 EURRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 14.9 | 11.0 | -10.6 | 6.2 | 5.8 | |
+/-Cat | -13.9 | -4.0 | 2.3 | 1.4 | 1.4 | |
+/-B’mrk | 2.7 | -8.7 | -2.9 | -9.0 | -3.3 | |
Category: Sector Equity Ecology | ||||||
Category Benchmark: Morningstar Gbl TME NR USD |
Key Stats | ||
NAV 23/04/2024 | EUR 1518.02 | |
Day Change | 0.66% | |
Morningstar Category™ | Sector Equity Ecology | |
ISIN | LU1865149980 | |
Fund Size (Mil) 23/04/2024 | EUR 180.52 | |
Share Class Size (Mil) 23/04/2024 | EUR 36.80 | |
Max Initial Charge | - | |
Ongoing Charge 16/02/2024 | 0.71% |
Investment Objective: Allianz Global Investors Fund - Allianz Climate Transition PT2 EUR |
Long-term capital growth by investing in European Equity markets with a focus on companies with an engagement in a transition into a low-carbon economy in accordance with the Sustainable and Responsible Investment Strategy (SRI Strategy). |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Christine Clet-Messadi 19/02/2019 | ||
Christophe Hautin 19/02/2019 | ||
Inception Date 19/02/2019 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | Morningstar Gbl TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Allianz Global Investors Fund - Allianz Climate Transition PT2 EUR | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 3.88 |
ASML Holding NV | Technology | 3.19 |
SAP SE | Technology | 2.95 |
Siemens AG | Industrials | 2.87 |
AstraZeneca PLC | Healthcare | 2.86 |
Increase Decrease New since last portfolio | ||
Allianz Global Investors Fund - Allianz Climate Transition PT2 EUR |